Comparison between Bio Medica Laboratories IPO and Natrinai Ventures IPO.
IPO Details
Bio Medica Laboratories IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Natrinai Ventures IPO is a SME Bookbuilding proposed to list at BSE SME.
Issue Size and Price
The total issue size of Bio Medica Laboratories IPO is up to ₹49.80 Cr whereas the issue size of the Natrinai Ventures IPO is up to ₹0.00 Cr. The final issue price of Bio Medica Laboratories IPO is ₹139.00 per share and of Natrinai Ventures IPO is .
| | Bio Medica Laboratories IPO | Natrinai Ventures IPO |
|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹132.00 per share | |
| Issue Price (Upper) | ₹139.00 per share | |
| Issue Price (Final) | ₹139.00 per share | |
| Discount (Retail) | | |
| Discount (Employee) | | |
| Market Lot Size | 1000 shares | |
| Fresh Issue Size | 32,06,000 shares | 41,40,000 shares |
| Fresh Issue Size (Amount) | up to ₹44.56 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 3,77,000 shares | 2,20,200 shares |
| OFS Issue Size (Amount) | up to ₹5.24 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,83,000 shares | 43,60,200 shares |
| Issue Size Total (Amount) | up to ₹49.80 Cr | up to ₹0.00 Cr |
IPO Timetable
Bio Medica Laboratories IPO opens on May 21, 2026, while Natrinai Ventures IPO opens on . The closing date of Bio Medica Laboratories IPO and Natrinai Ventures IPO is May 25, 2026, and , respectively.
Financials & KPIs
Bio Medica Laboratories IPO P/E ratio is 13.03, as compared to Natrinai Ventures IPO P/E ratio of .
Shares Offered
In the Bio Medica Laboratories IPO Retail Individual Investors (RII) are offered 17,92,000 shares while in Natrinai Ventures IPO retail investors are offered 17,92,000 shares. Qualified Institutional Buyers (QIB) are offered 36,000 shares in Bio Medica Laboratories IPO and 0 shares in Natrinai Ventures IPO.
Bids Received (Subscription)
Bio Medica Laboratories IPO subscribed 2.26x in total, whereas Natrinai Ventures IPO subscribed .
